[Antihypertensive activity of a new molecule, 2,6-dichloro-benzylidene aminoguanidine acetate].
The anti-hypertensive action of 2,6-dichlorobenzylideneaminoguanidine acetate (BR 750) is described. Inter-patient comparison pointed out its excellent tolerance, together with an anti-hypertensive activity at least equal to that of alpha-methyldopa.